Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul 7;25(1):27.
doi: 10.1186/s12199-020-00864-7.

Cumulative inactivated vaccine exposure and allergy development among children: a birth cohort from Japan

Collaborators, Affiliations

Cumulative inactivated vaccine exposure and allergy development among children: a birth cohort from Japan

Kiwako Yamamoto-Hanada et al. Environ Health Prev Med. .

Abstract

Background: Adjuvants used in inactivated vaccines often upregulate type 2 immunity, which is dominant in allergic diseases. We hypothesised that cumulative adjuvant exposure in infancy may influence the development of allergies later in life by changing the balance of type 1/type 2 immunity. We examined the relationship between immunisation with different vaccine types and later allergic disease development.

Methods: We obtained information regarding vaccinations and allergic diseases through questionnaires that were used in The Japan Environment and Children's Study (JECS), which is a nationwide, multicentre, prospective birth cohort study that included 103,099 pregnant women and their children. We examined potential associations between the initial vaccination before 6 months of age and symptoms related to allergies at 12 months of age.

Results: Our statistical analyses included 56,277 children. Physician-diagnosed asthma was associated with receiving three (aOR 1.395, 95% CI 1.028-1.893) or four to five different inactivated vaccines (aOR 1.544, 95% CI 1.149-2.075), compared with children who received only one inactivated vaccine. Similar results were found for two questionnaire-based symptoms, i.e. wheeze (aOR 1.238, 95% CI 1.094-1.401; three vaccines vs. a single vaccine) and eczema (aOR 1.144, 95% CI 1.007-1.299; four or five vaccines vs. a single vaccine).

Conclusions: Our results, which should be cautiously interpreted, suggest that the prevalence of asthma, wheeze and eczema among children at 12 months of age might be related to the amount of inactivated vaccine exposure before 6 months of age. Future work should assess if this association is due to cumulative adjuvant exposure. Despite this possible association, we strongly support the global vaccination strategy and recommend that immunisations continue.

Trial registration: UMIN000030786 .

Keywords: Adjuvant; Asthma; Eczema; Inactivated vaccine; Wheeze.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Similar articles

Cited by

References

    1. Marciani DJ. Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity. Drug Discov Today. 2003;8:934–943. doi: 10.1016/S1359-6446(03)02864-2. - DOI - PubMed
    1. Marrack P, McKee AS, Munks MW. Towards an understanding of the adjuvant action of aluminium. Nat Rev Immunol. 2009;9:287. doi: 10.1038/nri2510. - DOI - PMC - PubMed
    1. Centers for Disease Control and Prevention . Adjuvants help vaccines work better. 2018.
    1. Yamanishi R, Yusa I, Bando N, TERAO J. Adjuvant activity of alum in inducing antigen specific IgE antibodies in BALB/c mice: a reevaluation. Biosci Biotechnol Biochem. 2003;67:166–169. doi: 10.1271/bbb.67.166. - DOI - PubMed
    1. Kiraly N, Koplin JJ, Crawford NW, Bannister S, Flanagan KL, Holt PG, et al. Timing of routine infant vaccinations and risk of food allergy and eczema at one year of age. Allergy. 2016;71:541–549. doi: 10.1111/all.12830. - DOI - PubMed